Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Prediction and Pathogenesis of the Immune Reconstitution Inflammatory Syndrome (IRIS)

This study has been completed.
University Hospital Tuebingen
Albert Schweitzer Hospital
Information provided by (Responsible Party):
S. Janssen, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Identifier:
First received: March 16, 2012
Last updated: January 13, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)